EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

A Novel PMVK Variant Associated with Familial Porokeratosis

Wenjing Zhang, Xinmiao Nie, Lei Shi, Fengmin Shao, Lihua Cao

Human Heredity · 2023

DOI: 10.1159/000531120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Heredity, 2023. Verfasst von Wenjing Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Henan Provincial Clinical Research Center for Kidney Disease, Henan Provincial People's Hospital and People's Hospital of Z…. Hauptthemen laut MEDLINE: Porokeratosis. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Porokeratosis is a rare chronic progressive hypokeratotic skin disease, possibly related to the mevalonate pathway. Variations in four enzymes, including phosphomevalonate kinase (PMVK) may alter this pathway, ultimately leading to porokeratosis.

Objectives

The aim of the study was to identify the causative gene variant of porokeratosis in a Chinese family and investigate its population frequency and pathogenicity.

Method

In this study, Sanger sequencing was used to identify the gene variant causative of porokeratosis; its population frequency was investigated by polymerase chain reaction-restriction fragment length polymorphism in 4 patients and three normal individuals as well as in 100 normal unrelated controls; finally, the pathogenicity of the mutation and the associated structural changes were predicted.

Results

We identified a novel heterozygous missense variant, c.207G>T (p. Lys69Asn) in the PMVK gene. This variant was found in all patients but not in the normal individuals in this family or in the 100 controls. In silico analysis indicated that the variant was pathogenic; p.Lys69Asn changed the length of the α-helix and the hydrogen bond pattern compared with the wild-type protein.

Conclusions

The novel variant c.207G>T (p. Lys69Asn) in the PMVK gene was the causative variant in this porokeratosis family. This finding provides further evidence for the genetic basis of this disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PorokeratosisHumansMutationPhosphotransferases (Phosphate Group Acceptor)Mutation, MissensePedigree

Stichwörter der Autor:innen

Mevalonate pathwayPMVK genePhosphomevalonate kinasePorokeratosisVariation

Substanzen

phosphomevalonate kinasePhosphotransferases (Phosphate Group Acceptor)

Autor:innen und Institutionen

  • Department of Nephrology, Henan Provincial Clinical Research Center for Kidney Disease, Henan Provincial People's Hospital and People's Hospital of Zhengzhou University, Zhengzhou, China.
  • College of Kinesiology, Shenyang Sport University, Shenyang, China.
  • Department of Human Anatomy, College of Basic Medical Sciences, China Medical University, Shenyang, China.

Zitieren

APA

Zhang, W., Nie, X., Shi, L., Shao, F., & Cao, L. (2023). A Novel PMVK Variant Associated with Familial Porokeratosis. Human Heredity. https://doi.org/10.1159/000531120

Vancouver

Zhang W, Nie X, Shi L, Shao F, Cao L. A Novel PMVK Variant Associated with Familial Porokeratosis. Human Heredity. 2023. doi:10.1159/000531120

BibTeX
@article{Zhang2023,
  author = {Zhang, Wenjing and Nie, Xinmiao and Shi, Lei and Shao, Fengmin and Cao, Lihua},
  title = {A Novel PMVK Variant Associated with Familial Porokeratosis},
  journal = {Human Heredity},
  year = {2023},
  doi = {10.1159/000531120}
}
Kostenlos starten →